| Title |
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
|
|---|---|
| Published in |
Molecular Cancer Therapeutics, November 2007
|
| DOI | 10.1158/1535-7163.mct-07-0371 |
| Pubmed ID | |
| Authors |
Sean D McAllister, Rigel T Christian, Maxx P Horowitz, Amaia Garcia, Pierre-Yves Desprez |
X Demographics
The data shown below were collected from the profiles of 188 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 58 | 31% |
| Indonesia | 14 | 7% |
| Canada | 11 | 6% |
| United Kingdom | 9 | 5% |
| Australia | 3 | 2% |
| South Africa | 1 | <1% |
| Poland | 1 | <1% |
| Spain | 1 | <1% |
| Germany | 1 | <1% |
| Other | 12 | 6% |
| Unknown | 77 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 176 | 94% |
| Practitioners (doctors, other healthcare professionals) | 10 | 5% |
| Scientists | 2 | 1% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 296 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 1% |
| United Kingdom | 3 | 1% |
| Netherlands | 1 | <1% |
| Italy | 1 | <1% |
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 285 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 52 | 18% |
| Student > Master | 48 | 16% |
| Student > Ph. D. Student | 45 | 15% |
| Researcher | 44 | 15% |
| Other | 17 | 6% |
| Other | 31 | 10% |
| Unknown | 59 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 53 | 18% |
| Biochemistry, Genetics and Molecular Biology | 50 | 17% |
| Medicine and Dentistry | 39 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 5% |
| Chemistry | 15 | 5% |
| Other | 54 | 18% |
| Unknown | 70 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 581. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#40,930
of 25,738,558 outputs
Outputs from Molecular Cancer Therapeutics
#3
of 4,088 outputs
Outputs of similar age
#48
of 166,947 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 40 outputs
Altmetric has tracked 25,738,558 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,088 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,947 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.